Calidi Biotherapeutics, Inc. (CLDI)

Calidi Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.9	1.95	0.37	2.14	0.42
Cash & Short-Term Investments	1.9	1.95	0.37	2.14	0.42
Cash Growth	-81.30%	423.92%	-82.59%	408.81%	-
Prepaid Expenses	0.11	2.25	0.31	0.5	0.09
Restricted Cash	0.1	0.1	0.1	0.1	-
Total Current Assets	2.22	4.3	0.79	2.74	0.51
Property, Plant & Equipment	4.22	5.34	1.09	0.59	0.72
Long-Term Deferred Charges	-	-	-	-	0.62
Other Long-Term Assets	0.21	0.37	0.73	0.07	-
Total Assets	6.66	10.02	2.6	3.39	1.85
Accounts Payable	3.57	2.88	2.27	0.62	0.97
Accrued Expenses	3.58	5.43	5.35	3.51	1.54
Short-Term Debt	0.46	0.53	3.46	5	4.94
Current Portion of Long-Term Debt	2.63	0.28	1.96	-	-
Current Portion of Leases	1.23	1.12	0.12	0.14	0.34
Other Current Liabilities	0.1	-	29.83	16.69	1.1
Total Current Liabilities	11.58	10.23	42.99	25.96	8.89
Long-Term Debt	2.37	2.06	-	-	6.37
Long-Term Leases	2.33	3.25	0.45	0.04	0.07
Other Long-Term Liabilities	0.18	2.71	-	-	-
Total Liabilities	16.46	18.25	43.44	26	15.33
Common Stock	0	0	0	0	0
Additional Paid-In Capital	107.41	91.38	19.93	13.32	11.95
Retained Earnings	-117.62	-99.57	-70.36	-44.93	-34.44
Comprehensive Income & Other	-0.07	-0.05	-0.01	-0	0.01
Total Common Equity	-10.28	-8.24	-50.44	-31.61	-22.48
Shareholders' Equity	-9.8	-8.24	-40.84	-22.61	-13.48
Total Liabilities & Equity	6.66	10.02	2.6	3.39	1.85
Total Debt	9.02	7.24	5.99	5.18	11.72
Net Cash (Debt)	-7.13	-5.29	-5.62	-3.04	-11.3
Net Cash Per Share	-1.40	-3.13	-6.60	-1.54	-6.60
Filing Date Shares Outstanding	14.88	3.55	20.62	19.93	1.71
Total Common Shares Outstanding	11.11	3.55	20.62	19.93	1.71
Working Capital	-9.36	-5.93	-42.2	-23.22	-8.38
Book Value Per Share	-0.93	-2.32	-2.45	-1.59	-13.12
Tangible Book Value	-10.28	-8.24	-50.44	-31.61	-22.48
Tangible Book Value Per Share	-0.93	-2.32	-2.45	-1.59	-13.12
Machinery	1.67	1.66	1.1	0.68	0.46

Source: S&P Capital IQ. Standard template. Financial Sources.